222 related articles for article (PubMed ID: 16886588)
1. Bone mineral density and alterations of bone metabolism in children and adolescents with type 1 diabetes mellitus.
Karagüzel G; Akçurin S; Ozdem S; Boz A; Bircan I
J Pediatr Endocrinol Metab; 2006 Jun; 19(6):805-14. PubMed ID: 16886588
[TBL] [Abstract][Full Text] [Related]
2. The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study.
Lanes R; Gunczler P; Esaa S; Weisinger JR
Clin Endocrinol (Oxf); 2002 Dec; 57(6):725-30. PubMed ID: 12460321
[TBL] [Abstract][Full Text] [Related]
3. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
Kemink SA; Hermus AR; Swinkels LM; Lutterman JA; Smals AG
J Endocrinol Invest; 2000 May; 23(5):295-303. PubMed ID: 10882147
[TBL] [Abstract][Full Text] [Related]
4. Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally.
Gunczler P; Lanes R; Paz-Martinez V; Martins R; Esaa S; Colmenares V; Weisinger JR
J Pediatr Endocrinol Metab; 1998; 11(3):413-9. PubMed ID: 11517957
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
Jehle PM; Jehle DR; Mohan S; Böhm BO
J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
[TBL] [Abstract][Full Text] [Related]
6. Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism and bone mineral density.
Tsentidis C; Gourgiotis D; Kossiva L; Marmarinos A; Doulgeraki A; Karavanaki K
Pediatr Diabetes; 2016 Jun; 17(4):289-99. PubMed ID: 26094958
[TBL] [Abstract][Full Text] [Related]
7. Relationship between bone formation markers bone alkaline phosphatase, osteocalcin and amino-terminal propeptide of type I collagen and bone mineral density in elderly men. Preliminary results.
Lumachi F; Orlando R; Fallo F; Basso SM
In Vivo; 2012; 26(6):1041-4. PubMed ID: 23160690
[TBL] [Abstract][Full Text] [Related]
8. A 1-year prospective study on the relationship between physical activity, markers of bone metabolism, and bone acquisition in peripubertal girls.
Lehtonen-Veromaa M; Möttönen T; Irjala K; Nuotio I; Leino A; Viikari J
J Clin Endocrinol Metab; 2000 Oct; 85(10):3726-32. PubMed ID: 11061531
[TBL] [Abstract][Full Text] [Related]
9. Decreased bone mineral density and bone formation markers shortly after diagnosis of clinical type 1 diabetes mellitus.
Gunczler P; Lanes R; Paoli M; Martinis R; Villaroel O; Weisinger JR
J Pediatr Endocrinol Metab; 2001 May; 14(5):525-8. PubMed ID: 11393573
[TBL] [Abstract][Full Text] [Related]
10. Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization.
Colao A; Di Somma C; Loche S; Di Sarno A; Klain M; Pivonello R; Pietrosante M; Salvatore M; Lombardi G
Clin Endocrinol (Oxf); 2000 Mar; 52(3):319-27. PubMed ID: 10718830
[TBL] [Abstract][Full Text] [Related]
11. Lumbar spine bone mineral density in diabetic children with recent onset.
De Schepper J; Smitz J; Rosseneu S; Bollen P; Louis O
Horm Res; 1998; 50(4):193-6. PubMed ID: 9838239
[TBL] [Abstract][Full Text] [Related]
12. Bone metabolism markers and bone mineral density in children with neurofibromatosis type-1.
Duman O; Ozdem S; Turkkahraman D; Olgac ND; Gungor F; Haspolat S
Brain Dev; 2008 Oct; 30(9):584-8. PubMed ID: 18362054
[TBL] [Abstract][Full Text] [Related]
13. The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure.
Tsuchida T; Ishimura E; Miki T; Matsumoto N; Naka H; Jono S; Inaba M; Nishizawa Y
Osteoporos Int; 2005 Feb; 16(2):172-9. PubMed ID: 15164161
[TBL] [Abstract][Full Text] [Related]
14. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
Katagiri M; Fukunaga M; Ohtawa T; Harada T
World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
[TBL] [Abstract][Full Text] [Related]
15. An association between abnormal bone turnover, systemic inflammation, and osteoporosis in patients with chronic pancreatitis: a case-matched study.
Duggan SN; Purcell C; Kilbane M; O'Keane M; McKenna M; Gaffney P; Ridgway PF; Boran G; Conlon KC
Am J Gastroenterol; 2015 Feb; 110(2):336-45. PubMed ID: 25623657
[TBL] [Abstract][Full Text] [Related]
16. Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis.
Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Shin CS
Endocr J; 2005 Dec; 52(6):667-74. PubMed ID: 16410657
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of bone mineral density and selected metabolic markers of bone in boys with constitutional delay of growth and puberty].
Krupa B
Ann Acad Med Stetin; 2000; 46():165-76. PubMed ID: 11712302
[TBL] [Abstract][Full Text] [Related]
18. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
Tsentidis C; Gourgiotis D; Kossiva L; Doulgeraki A; Marmarinos A; Galli-Tsinopoulou A; Karavanaki K
Osteoporos Int; 2016 Apr; 27(4):1631-1643. PubMed ID: 26588909
[TBL] [Abstract][Full Text] [Related]
19. Bone metabolism is linked to disease duration and metabolic control in type 1 diabetes mellitus.
Brandao FR; Vicente EJ; Daltro CH; Sacramento M; Moreira A; Adan L
Diabetes Res Clin Pract; 2007 Dec; 78(3):334-9. PubMed ID: 17582646
[TBL] [Abstract][Full Text] [Related]
20. Femoral neck osteopenia in patients with inflammatory bowel disease.
Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]